Depigmentation therapy

Dermatologic Therapy

Volumn 14, Issue 1, 2001, Pages 29-34

  Bolognia, Jean L ^a   Lapia, Kim ^a   Somma, Sandra ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depigmentation; MBEH; Monobenzone; Monobenzylether of hydroquinone; Vitiligo

Indexed keywords

MEQUINOL; MONOBENZONE;

ARTICLE; CONTACT DERMATITIS; DEPIGMENTATION; DRUG COST; DRUG EFFICACY; HUMAN; LASER SURGERY; MELANOCYTE; PUVA; VITILIGO;

EID: 0035081520     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8019.2001.014001029.x     Document Type: Article

References (15)

1. A depigmentation of the skin
2. Occupational leukoderma
3. Treatment of melanin hyperpigmentation
4. Evaluation of monobenzone
5. Leukomelanoderma subsequent to the application of monobenzyl ether of hydroquinone
6. Leukomelanoderma in blacks. A recent epidemic
7. Effect of monobenzyl hydroquinone on oxidase systems in vivo and in vitro
8. Different populations of melanocytes are present in hair follicles and epidermis
9. Monobenzylether of hydroquinone
10. Rapid repigmentation after depigmentation therapy: Vitiligo treated with monobenzylether of hydroquinone
11. Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo
12. Dermatitis produced by applications of monobenzone in patients with active vitiligo
13. Diminished contact sensitivity response in vitiliginous skin
14. Corneal and conjunctival effects of monobenzone in patients with vitiligo
15. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser